LXU:NYE-Lsb Industries Inc (USD)

COMMON STOCK | Chemicals |

Last Closing

USD 8.46

Change

+0.15 (+1.81)%

Market Cap

N/A

Volume

0.33M

Analyst Target

USD 8.07
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Chemicals

Symbol Name Price(Change) Market Cap
HUN Huntsman Corporation

+0.50 (+2.11%)

USD 4.25B
BAK Braskem SA Class A

+0.10 (+1.37%)

USD 2.98B
TROX Tronox Holdings PLC

+0.11 (+0.78%)

USD 2.30B
VHI Valhi Inc

+2.37 (+7.34%)

USD 0.94B
ASIX AdvanSix Inc

+0.81 (+2.60%)

USD 0.83B
WLKP Westlake Chemical Partners LP

N/A

USD 0.79B
RYAM Rayonier Advanced Materials

+0.19 (+2.21%)

USD 0.56B
DOW Dow Inc

+0.84 (+1.54%)

N/A
CE Celanese Corporation

+2.77 (+2.07%)

N/A
REX REX American Resources Corpora..

+0.55 (+1.21%)

N/A

ETFs Containing LXU

CLMT:CA 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Chemicals) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.13% 27% F 15% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.13% 27% F 14% F
Trailing 12 Months  
Capital Gain -12.87% 9% A- 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -12.87% 9% A- 10% F
Trailing 5 Years  
Capital Gain 67.19% 73% C 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 67.19% 73% C 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 96.93% N/A N/A 97% N/A
Dividend Return 96.93% N/A N/A 97% N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 169.70% N/A N/A 4% F
Risk Adjusted Return 57.12% N/A N/A 74% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:

There is nothing we particularly dislike